National Guideline Clearinghouse | Optimal use recommendations for second- and third-line therapy for patients with type 2 diabetes.

full-text ►

National Guideline Clearinghouse | Optimal use recommendations for second- and third-line therapy for patients with type 2 diabetes.





Canadian Agency for Drugs and Technologies in Health

February 3, 2014

Guideline Title

Optimal use recommendations for second- and third-line therapy for patients with type 2 diabetes.

Bibliographic Source(s)

Canadian Agency for Drugs and Technologies in Health (CADTH). Optimal use recommendations for second and third-line therapy for patients with type 2 diabetes. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health (CADTH); 2013 Jul. 19 p. [13 references]

Guideline Status

This is the current release of the guideline.